全文获取类型
收费全文 | 6699篇 |
免费 | 336篇 |
国内免费 | 63篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 197篇 |
妇产科学 | 149篇 |
基础医学 | 667篇 |
口腔科学 | 150篇 |
临床医学 | 452篇 |
内科学 | 1705篇 |
皮肤病学 | 127篇 |
神经病学 | 386篇 |
特种医学 | 531篇 |
外科学 | 1213篇 |
综合类 | 18篇 |
预防医学 | 223篇 |
眼科学 | 54篇 |
药学 | 299篇 |
中国医学 | 8篇 |
肿瘤学 | 862篇 |
出版年
2024年 | 6篇 |
2023年 | 86篇 |
2022年 | 107篇 |
2021年 | 252篇 |
2020年 | 155篇 |
2019年 | 219篇 |
2018年 | 272篇 |
2017年 | 170篇 |
2016年 | 195篇 |
2015年 | 202篇 |
2014年 | 309篇 |
2013年 | 359篇 |
2012年 | 504篇 |
2011年 | 518篇 |
2010年 | 284篇 |
2009年 | 252篇 |
2008年 | 405篇 |
2007年 | 388篇 |
2006年 | 342篇 |
2005年 | 405篇 |
2004年 | 341篇 |
2003年 | 313篇 |
2002年 | 265篇 |
2001年 | 40篇 |
2000年 | 38篇 |
1999年 | 45篇 |
1998年 | 67篇 |
1997年 | 53篇 |
1996年 | 49篇 |
1995年 | 39篇 |
1994年 | 29篇 |
1993年 | 25篇 |
1992年 | 23篇 |
1991年 | 20篇 |
1990年 | 42篇 |
1989年 | 43篇 |
1988年 | 43篇 |
1987年 | 46篇 |
1986年 | 45篇 |
1985年 | 23篇 |
1984年 | 14篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1977年 | 5篇 |
1971年 | 3篇 |
1968年 | 3篇 |
1966年 | 6篇 |
1965年 | 4篇 |
排序方式: 共有7098条查询结果,搜索用时 406 毫秒
991.
Giovanni Del Poeta Annalisa Biagi Luca Laurenti Annalisa Chiarenza Federico Pozzo Idanna Innocenti Massimiliano Postorino Francesca Maria Rossi Maria Ilaria Del Principe Riccardo Bomben Paolo de Fabritiis Antonio Bruno Maria Cantonetti Francesco Di Raimondo Antonella Zucchetto Valter Gattei 《Haematologica》2021,106(9):2345
The introduction of agents inhibiting the B-cell receptor-associated kinases such as ibrutinib has dramatically changed treatments algorithms of chronic lymphocytic leukemia (CLL) as well as the role of different adverse prognosticators. We evaluated the efficacy of ibrutinib as a single agent, in a real-life context, in 180 patients with CLL mostly pretreated, recruited from three independent cohorts from Italy. Patients received 420 mg oral ibrutinib once daily until progression or occurrence of unacceptable side effects. Seventy-three patients discontinued ibrutinib for progression or for adverse events. NOTCH1 mutations (NOTCH1 M) were correlated with a reduced redistribution lymphocytosis, calculated at 3 months on ibrutinib (P=0.022). Moreover, NOTCH1 M patients showed inferior nodal response at 6 months on ibrutinib compared to NOTCH1 wild-type patients (P<0.0001). Significant shorter progression free survival (PFS) and overall survival (OS) were observed in NOTCH1 M patients (P=0.00002 and P=0.001). Interestingly, NOTCH1 M plus a lower BAX/BCL-2 ratio identified a CLL subset showing the worst PFS and OS (P=0.0002 and P=0.005). In multivariate analysis of PFS and OS, NOTCH1 M were confirmed an independent prognosticator (P=0.00006 and P=0.0039). In conclusion, NOTCH1 M are strongly associated with a lower BAX/BCL-2 ratio, consistent with defective apoptosis, lower redistribution lymphocytosis and lower nodal shrinkage under ibrutinib treatment, this last paramter being responsible for partial responses, subsequent relapses, as well as shorter PFS and OS. Either new small molecule combination approaches or antibodies targeting NOTCH1 could be future therapeutic options for NOTCH1 M patients. 相似文献
992.
993.
994.
995.
Hormone replacement therapy (HRT) in young postmenopausal women is a safe and effective tool to counteract climacteric symptoms and to prevent long-term degenerative diseases, such as osteoporotic fractures, cardiovascular disease, diabetes mellitus and possibly cognitive impairment. The different types of HRT offer to many extent comparable efficacies on symptoms control; however, the expert selection of specific compounds, doses or routes of administration can provide significant clinical advantages. This paper reviews the role of the non-oral route of administration of sex steroids in the clinical management of postmenopausal women. Non-orally administered estrogens, minimizing the hepatic induction of clotting factors and others proteins associated with the first-pass effect, are associated with potential advantages on the cardiovascular system. In particular, the risk of developing deep vein thrombosis or pulmonary thromboembolism is negligible in comparison to that associated with oral estrogens. In addition, recent indications suggest potential advantages for blood pressure control with non-oral estrogens. To the same extent, a growing literature suggests that the progestins used in association with estrogens may not be equivalent. Recent evidence indeed shows that natural progesterone displays a favorable action on the vessels and on the brain, while this might not be true for some synthetic progestins. Compelling indications also exist that differences might also be present for the risk of developing breast cancer, with recent trials indicating that the association of natural progesterone with estrogens confers less or even no risk of breast cancer as opposed to the use of other synthetic progestins. In conclusion, while all types of hormone replacement therapies are safe and effective and confer significant benefits in the long-term when initiated in young postmenopausal women, in specific clinical settings the choice of the transdermal route of administration of estrogens and the use of natural progesterone might offer significant benefits and added safety. 相似文献
996.
OBJECTIVES: The aim of the present study was to evaluate the effects of low doses of hormone replacement therapy (HRT) in normal young postmenopausal women. METHODS: In an open trial healthy, non-obese postmenopausal women received for 2 years a low-dose continuous combined HRT (LD-HRT) containing 1mg estradiol+0.5 mg norethisterone acetate each pill for 28 days, or 0.5 mg of 17beta-estradiol and 0.25 mg of norethisterone acetate (Ultra low dose, Ultra-LD-HRT) along with 1000 mg of calcium per day. Control group consisted of women receiving only 1000 mg of calcium per day, for 2 years. Menopausal symptoms were evaluated by the Green climacteric scale for the first 12 weeks of the study while bleeding profiles, bone mineral density (BMD) and bone turnover were assessed for 24 months. RESULTS: LD-HRT and Ultra-LD-HRT were effective in reducing menopausal clinical symptoms. In the control group, BMD significantly (P<0.05) decreased at the spine (-2.8+/-0.2%), and femoral neck (-2.8+/-0.7%). In LD-HRT treated group BMD showed a significant (P<0.05) increase at the spine (5.2+/-0.7%), and femoral neck (2.8+/-0.4%) after 24 months. In the Ultra-LD-HRT treated women spine and femoral neck BMD showed a significant (P<0.05) increase (2.0+/-0.3 and 1.8+/-0.3%, respectively) after 24 months. In these women treated with LD-HRT and Ultra-LD-HRT the BMD values were significantly (P<0.05) different from those measured in calcium-treated women. CONCLUSIONS: LD-HRT and Ultra-LD-HRT can alleviate subjective symptoms providing an effective protection against the postmenopausal decrease of BMD. 相似文献
997.
998.
Asero R Mistrello G Roncarolo D Amato S 《International archives of allergy and immunology》2008,145(4):340-342
This case report describes a patient with bee moth-induced rhinoconjunctivitis, asthma and contact urticaria. Immunoblot analysis showed IgE reactivity to two distinct bee moth proteins at 23 and 70 kDa, respectively. ELISA inhibition studies excluded cross-reactivity to the other popular live bait, fly larva. 相似文献
999.
Petti CA Simmon KE Miro JM Hoen B Marco F Chu VH Athan E Bukovski S Bouza E Bradley S Fowler VG Giannitsioti E Gordon D Reinbott P Korman T Lang S Garcia-de-la-Maria C Raglio A Morris AJ Plesiat P Ryan S Doco-Lecompte T Tripodi F Utili R Wray D Federspiel JJ Boisson K Reller LB Murdoch DR Woods CW;International Collaboration on Endocarditis-Microbiology Investigators 《Journal of clinical microbiology》2008,46(5):1780-1784
Coagulase-negative staphylococci (CNS) are important causes of infective endocarditis (IE), but their microbiological profiles are poorly described. We performed DNA target sequencing and susceptibility testing for 91 patients with definite CNS IE who were identified from the International Collaboration on Endocarditis-Microbiology, a large, multicenter, multinational consortium. A hierarchy of gene sequences demonstrated great genetic diversity within CNS from patients with definite endocarditis that represented diverse geographic regions. In particular, rpoB sequence data demonstrated unique genetic signatures with the potential to serve as an important tool for global surveillance. 相似文献
1000.
Belvederesi L Bianchi F Galizia E Loretelli C Bracci R Catalani R Amati M Cellerino R 《Human mutation》2008,29(11):E296-E309
Hereditary Non-Polyposis Colorectal Cancer (HNPCC) is associated with germline mutations in one of several MisMatch Repair (MMR) genes. An increasing proportion (20-25%) of the reported MSH2 variants consists of single amino-acid substitution with uncertain disease-causing significance. The present study was undertaken to functionally characterize 3 MSH2 nontruncating variants: p.Gly162Arg (c.484G>C), p.Asp167His (c.499G>C) and p.Arg359Ser (c.1077A>T). Missense alterations, were assessed in a human system for expression/stability and for the ability to heterodimerize with MSH6 and correctly localize into the nucleus. Functional assays results were correlated with clinical and genetic features indicative of HNPCC as MicroSatellite-Instability (MSI), abnormalities of MMR gene expression in tumour tissue (IHC) and familial history. p.Gly162Arg and p.Arg359Ser variants showed a clearly decreased expression level of the MutSá complex and were associated with an abnormal subcellular localization pattern, which can be suggestive of an incorrect MSH2/MSH6 heterodimerization. Functional analysis results were supported by MSI and IHC data and by familial cancer history. The subcellular localization assay, performed in a human expression system, classifies as pathogenetic two MSH2 nontruncating alterations providing a useful tool in genetic testing programs. 相似文献